{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:10:40Z","timestamp":1793398240071,"version":"4.5.0"},"reference-count":53,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,26]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Dysregulation of the bone marrow (BM) niche in multiple myeloma (MM) alters the composition and state of resident immune cells, potentially impeding antitumor immunity. One common mechanism of immune inhibition in solid tumors is the induction of exhaustion in tumor-specific T cells. However, the extent of T-cell exhaustion is not well characterized in MM. As the specific mechanisms of immune evasion are critical for devising effective therapeutic strategies, we deeply profiled the CD8+ T-cell compartment of patients with newly diagnosed MM (NDMM) for evidence of T-cell activation and exhaustion. We applied single-cell multiomic sequencing and mass cytometry to longitudinal BM and peripheral blood (PB) samples taken from time points spanning from diagnosis to induction therapy, autologous stem cell transplant, and maintenance therapy. We identified an exhausted-like population that lacked several canonical exhaustion markers, was not significantly enriched in patients with NDMM, and consisted of small, nonpersistent clonotypes. We also observed an activated population with increased frequency in the PB of patients with NDMM exhibiting phenotypic and clonal features consistent with homeostatic, cytokine-driven activation. As an orthogonal measurement of T-cell exhaustion, we performed intracellular cytokine staining and found that patients with NDMM lacked functionally exhausted T cells. In summary, there was no evidence of \u201ctumor-experienced\u201d T cells displaying hallmarks of terminal exhaustion and\/or antigen-driven activation\/expansion in patients with NDMM at any time point.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2024025655","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T17:05:09Z","timestamp":1743440709000},"page":"3113-3123","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":23,"title":["Hallmarks of T-cell exhaustion and antigen experience are absent in multiple myeloma from diagnosis to maintenance therapy"],"prefix":"10.1182","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3021-9383","authenticated-orcid":false,"given":"Carolyn","family":"Shasha","sequence":"first","affiliation":[{"name":"1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9924-167X","authenticated-orcid":false,"given":"David R.","family":"Glass","sequence":"additional","affiliation":[{"name":"1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7664-8091","authenticated-orcid":false,"given":"Ernest","family":"Moelhman","sequence":"additional","affiliation":[{"name":"1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1465-3718","authenticated-orcid":false,"given":"Laura","family":"Islas","sequence":"additional","affiliation":[{"name":"1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6073-8582","authenticated-orcid":false,"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[{"name":"1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3273-5549","authenticated-orcid":false,"given":"Tony","family":"Chour","sequence":"additional","affiliation":[{"name":"1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7699-8837","authenticated-orcid":false,"given":"Guoyue","family":"Xu","sequence":"additional","affiliation":[{"name":"1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7604-1333","authenticated-orcid":false,"given":"Gregory L.","family":"Szeto","sequence":"additional","affiliation":[{"name":"3Allen Institute for Immunology, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0550-9183","authenticated-orcid":false,"given":"Tao","family":"Peng","sequence":"additional","affiliation":[{"name":"3Allen Institute for Immunology, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5969-4025","authenticated-orcid":false,"given":"Xiaoling","family":"Song","sequence":"additional","affiliation":[{"name":"2Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8862-5255","authenticated-orcid":false,"given":"Michelle","family":"Wurscher","sequence":"additional","affiliation":[{"name":"1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1880-7094","authenticated-orcid":false,"given":"Andrew J.","family":"Cowan","sequence":"additional","affiliation":[{"name":"4Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"5Department of Medicine, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4319-1006","authenticated-orcid":false,"given":"Thomas F.","family":"Bumol","sequence":"additional","affiliation":[{"name":"3Allen Institute for Immunology, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3489-5036","authenticated-orcid":false,"given":"Troy R.","family":"Torgerson","sequence":"additional","affiliation":[{"name":"3Allen Institute for Immunology, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3812-647X","authenticated-orcid":false,"given":"Philip D.","family":"Greenberg","sequence":"additional","affiliation":[{"name":"2Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"5Department of Medicine, University of Washington, Seattle, WA"},{"name":"6Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"7Department of Immunology, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0477-1446","authenticated-orcid":false,"given":"Damian J.","family":"Green","sequence":"additional","affiliation":[{"name":"6Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2889-243X","authenticated-orcid":false,"given":"Evan W.","family":"Newell","sequence":"additional","affiliation":[{"name":"1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2025062611220176600_bib1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"issue":"17","key":"2025062611220176600_bib2","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1200\/JCO.19.02515","article-title":"Long-term follow-up results of lenalidomide, bortezomib, and dexamethasone induction therapy and risk-adapted maintenance approach in newly diagnosed multiple myeloma","volume":"38","author":"Joseph","year":"2020","journal-title":"JCO"},{"issue":"2","key":"2025062611220176600_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0953-6205(01)00205-9","article-title":"Current treatment strategies for multiple myeloma","volume":"13","author":"Grosbois","year":"2002","journal-title":"Eur J Intern Med"},{"issue":"12","key":"2025062611220176600_bib4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"2025062611220176600_bib5","doi-asserted-by":"crossref","first-page":"715234","DOI":"10.3389\/fimmu.2021.715234","article-title":"CD8+ T cell exhaustion in cancer","volume":"12","author":"Dolina","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"2025062611220176600_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccell.2022.03.012","article-title":"A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers","volume":"40","author":"Hanada","year":"2022","journal-title":"Cancer Cell"},{"issue":"10","key":"2025062611220176600_bib7","doi-asserted-by":"crossref","first-page":"e1005177","DOI":"10.1371\/journal.ppat.1005177","article-title":"CD39 expression identifies terminally exhausted CD8+ T cells","volume":"11","author":"Gupta","year":"2015","journal-title":"PLoS Pathog"},{"issue":"4","key":"2025062611220176600_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+ T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2025062611220176600_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.it.2013.10.001","article-title":"Tolerance and exhaustion: defining mechanisms of T cell dysfunction","volume":"35","author":"Schietinger","year":"2014","journal-title":"Trends Immunol"},{"issue":"2","key":"2025062611220176600_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cancers13020217","article-title":"The role of tumor microenvironment in multiple myeloma development and progression","volume":"13","author":"Garc\u00eda-Ortiz","year":"2021","journal-title":"Cancers"},{"issue":"7706","key":"2025062611220176600_bib11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","article-title":"Bystander CD8 + T cells are abundant and phenotypically distinct in human tumour infiltrates","volume":"557","author":"Simoni","year":"2018","journal-title":"Nature"},{"key":"2025062611220176600_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-1-4939-9454-0_5","article-title":"Scalable conjugation and characterization of immunoglobulins with stable mass isotope reporters for single-cell mass cytometry analysis","volume":"1989","author":"Hartmann","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"10","key":"2025062611220176600_bib13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1182\/blood-2015-04-640532","article-title":"The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell\u2013based immunotherapy","volume":"126","author":"Walz","year":"2015","journal-title":"Blood"},{"issue":"7","key":"2025062611220176600_bib14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00262-011-1009-3","article-title":"Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma","volume":"60","author":"Anderson","year":"2011","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"2025062611220176600_bib15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1084\/jem.20062387","article-title":"Frequent and specific immunity to the embryonal stem cell\u2013associated antigen SOX2 in patients with monoclonal gammopathy","volume":"204","author":"Spisek","year":"2007","journal-title":"J Exp Med"},{"key":"2025062611220176600_bib16","doi-asserted-by":"crossref","first-page":"302145","DOI":"10.1155\/2011\/302145","article-title":"Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation","volume":"2011","author":"Kobold","year":"2011","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"2025062611220176600_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/bioinformatics\/btz474","article-title":"arcasHLA: high-resolution HLA typing from RNAseq","volume":"36","author":"Orenbuch","year":"2020","journal-title":"Bioinformatics"},{"key":"2025062611220176600_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-1-4939-9454-0_11","article-title":"Multiplex MHC class I tetramer combined with intranuclear staining by mass cytometry","volume":"1989","author":"Simoni","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"5","key":"2025062611220176600_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/cyto.a.22271","article-title":"Normalization of mass cytometry data with bead standards","volume":"83","author":"Finck","year":"2013","journal-title":"Cytometry A"},{"issue":"5","key":"2025062611220176600_bib20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cels.2018.02.010","article-title":"Compensation of signal spillover in suspension and imaging mass cytometry","volume":"6","author":"Chevrier","year":"2018","journal-title":"Cell Syst"},{"issue":"1","key":"2025062611220176600_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol"},{"issue":"4","key":"2025062611220176600_bib22","first-page":"281","article-title":"Scrublet: computational identification of cell doublets in single-cell transcriptomic data","volume":"8","author":"Wolock","year":"2019","journal-title":"cels"},{"issue":"18","key":"2025062611220176600_bib23","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1093\/bioinformatics\/btaa611","article-title":"Scirpy: a Scanpy extension for analyzing single-cell T-cell receptor-sequencing data","volume":"36","author":"Sturm","year":"2020","journal-title":"Bioinformatics"},{"issue":"3","key":"2025062611220176600_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41592-020-01050-x","article-title":"Joint probabilistic modeling of single-cell multi-omic data with totalVI","volume":"18","author":"Gayoso","year":"2021","journal-title":"Nat Methods"},{"issue":"6574","key":"2025062611220176600_bib25","doi-asserted-by":"crossref","first-page":"abe6474","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"issue":"3","key":"2025062611220176600_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat Methods"},{"issue":"1","key":"2025062611220176600_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.immuni.2012.01.002","article-title":"Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes","volume":"36","author":"Newell","year":"2012","journal-title":"Immunity"},{"issue":"2","key":"2025062611220176600_bib28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/infdis\/jiac260","article-title":"Analysis of the HIV vaccine trials network 702 phase 2b\u20133 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk","volume":"226","author":"Moodie","year":"2022","journal-title":"J Infect Dis"},{"issue":"3","key":"2025062611220176600_bib29","doi-asserted-by":"crossref","first-page":"110728","DOI":"10.1016\/j.celrep.2022.110728","article-title":"Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets","volume":"39","author":"Glass","year":"2022","journal-title":"Cell Rep"},{"issue":"6","key":"2025062611220176600_bib30","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"issue":"6","key":"2025062611220176600_bib31","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1002\/cam4.2113","article-title":"Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq","volume":"8","author":"Song","year":"2019","journal-title":"Cancer Med"},{"issue":"7735","key":"2025062611220176600_bib32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","article-title":"Lineage tracking reveals dynamic relationships of T cells in colorectal cancer","volume":"564","author":"Zhang","year":"2018","journal-title":"Nature"},{"issue":"9","key":"2025062611220176600_bib33","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41592-022-01578-0","article-title":"VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2","volume":"19","author":"Goncharov","year":"2022","journal-title":"Nat Methods"},{"issue":"9","key":"2025062611220176600_bib34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41577-019-0180-1","article-title":"Mechanisms underlying T cell ageing","volume":"19","author":"Goronzy","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2025062611220176600_bib35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/icb.2012.69","article-title":"IL-7 downregulates IL-7R\u03b1 expression in human CD8 T cells by two independent mechanisms","volume":"91","author":"Ghazawi","year":"2013","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"2025062611220176600_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","volume":"37","author":"Becht","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"49","key":"2025062611220176600_bib37","doi-asserted-by":"crossref","first-page":"eaba7918","DOI":"10.1126\/sciimmunol.aba7918","article-title":"TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells","volume":"5","author":"Sekine","year":"2020","journal-title":"Sci Immunol"},{"issue":"20","key":"2025062611220176600_bib38","doi-asserted-by":"crossref","first-page":"13009","DOI":"10.1073\/pnas.202491499","article-title":"T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells","volume":"99","author":"Dhodapkar","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2025062611220176600_bib39","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/2326-6066.CIR-22-0434","article-title":"Immune phenotypes and target antigens of clonally expanded bone marrow T cells in treatment-na\u00efve multiple myeloma","volume":"10","author":"Welters","year":"2022","journal-title":"Cancer Immunol Res"},{"issue":"26","key":"2025062611220176600_bib40","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1182\/blood-2009-10-246660","article-title":"Elevated IL-17 produced by Th17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma","volume":"115","author":"Prabhala","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2025062611220176600_bib41","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/bjc.2011.575","article-title":"The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma","volume":"106","author":"Giannopoulos","year":"2012","journal-title":"Br J Cancer"},{"issue":"16","key":"2025062611220176600_bib42","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1182\/blood-2018-01-825265","article-title":"TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma","volume":"132","author":"Guillerey","year":"2018","journal-title":"Blood"},{"key":"2025062611220176600_bib43","doi-asserted-by":"crossref","first-page":"651288","DOI":"10.3389\/fimmu.2021.651288","article-title":"Autologous stem cell transplantation for myeloma: cytoreduction or an immunotherapy?","volume":"12","author":"Minnie","year":"2021","journal-title":"Front Immunol"},{"issue":"16","key":"2025062611220176600_bib44","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2018-01-825240","article-title":"Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade [published correction appears in Blood. 2019;134(21):1878]","volume":"132","author":"Minnie","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2025062611220176600_bib45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI98888","article-title":"Bone marrow transplantation generates T cell\u2013dependent control of myeloma in mice","volume":"129","author":"Vuckovic","year":"2019","journal-title":"J Clin Invest"},{"issue":"6","key":"2025062611220176600_bib46","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41590-021-00927-z","article-title":"Hallmarks of T cell aging","volume":"22","author":"Mittelbrunn","year":"2021","journal-title":"Nat Immunol"},{"issue":"94","key":"2025062611220176600_bib47","doi-asserted-by":"crossref","first-page":"eadg1094","DOI":"10.1126\/sciimmunol.adg1094","article-title":"TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies","volume":"9","author":"Minnie","year":"2024","journal-title":"Sci Immunol"},{"issue":"8","key":"2025062611220176600_bib48","doi-asserted-by":"crossref","first-page":"e120505","DOI":"10.1172\/jci.insight.120505","article-title":"Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma [published correction appears in JCI Insight. 2019;4(4):e127684]","volume":"3","author":"Garfall","year":"2018","journal-title":"JCI Insight"},{"issue":"21","key":"2025062611220176600_bib49","doi-asserted-by":"crossref","first-page":"15674","DOI":"10.3390\/ijms242115674","article-title":"Immunotherapy of multiple myeloma: current status as prologue to the future","volume":"24","author":"Abramson","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2025062611220176600_bib50","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","article-title":"A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade","volume":"24","author":"Thommen","year":"2018","journal-title":"Nat Med"},{"issue":"11","key":"2025062611220176600_bib51","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ccell.2021.10.001","article-title":"Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma","volume":"39","author":"Au","year":"2021","journal-title":"Cancer Cell"},{"issue":"7528","key":"2025062611220176600_bib52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"key":"2025062611220176600_bib53","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fimmu.2019.00168","article-title":"Cold tumors: a therapeutic challenge for immunotherapy","volume":"10","author":"Bonaventura","year":"2019","journal-title":"Front Immunol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/26\/3113\/2382819\/blood_bld-2024-025655-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/26\/3113\/2382819\/blood_bld-2024-025655-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T11:22:17Z","timestamp":1750936937000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/145\/26\/3113\/536435\/Hallmarks-of-T-cell-exhaustion-and-antigen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":53,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2025,6,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024025655","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6,26]]},"published":{"date-parts":[[2025,6,26]]}}}